PACTR201804003188338招募中未知
A Randomized, 28-days, Parallel-group, Equivalence Study to Compare the Effectiveness of 10mg Fe2+ Spatone Iron-Plus and 60mg Fe2+ Ferrous sulphate in Improving Haemoglobin Status of Pregnant Women in Lagos University Teaching Hospital
Dr. George Obioma-Okorie0 个研究点目标入组 200 人开始时间: 2018年3月13日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 44 Year(s)（—）
- 性别
- Female
入选标准
- •Subjects willing and able to give informed consent for participation in the trial
- •Pregnant women who have a singleton fetus
- •Aged 18 to 44 years
- •Gestational age between 14 and 27 weeks of pregnancy
排除标准
- •Pregnant women with multifetal pregnancy
- •History of allergy to iron containing preparation
- •History of chronic medical conditions such as chronic renal failure, haemoglobinopathy
- •History of chronic inflammatory/infectious diseases such as tuberculosis or HIV infection in pregnancy
- •Inability to return for follow-up visit at 4 weeks after enrolment
- •Severe anaemia or anaemia with clinical features of cardiac failure
研究者
相似试验
尚未招募
不适用
Effect of Albendazole in combination with Ivermectin in treatment of soil transmitted heminthiasisCTRI/2022/01/039738MANKIND PHARMA LTD
进行中（未招募）
3 期
Clinical trial to compare effects and safety of Lupins Ranibizumab with Lucentis�® in Patients with Age-Related loss of central vision.CTRI/2019/03/018322upin Limited Biotechnology Division
进行中（未招募）
1 期
A Randomized, Double-Blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the Efficacy and Safety of Fusidic Acid Hydrophilic Cream 20 mg/g and Fucidin® Cream in the Treatment of Adult and Pediatric Subjects with Impetigo.Impetigo contagiosaMedDRA version: 20.0Level: PTClassification code 10021531Term: ImpetigoSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10041923Term: Staphylococcal impetigoSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10042178Term: Streptococcal impetigoSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10021535Term: Impetigo NOSSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: LLTClassification code 10041939Term: Staphylococcus aureus impetigoSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10042200Term: Streptococcus pyogenes impetigoSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: LLTClassification code 10021533Term: Impetigo contagiousSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-002219-24-BEBasic Pharma Technologies200
进行中（未招募）
1 期
AN EQUIVALENCE TRIAL TO COMPARE THE EFFICACY, SAFETY, PHARMACOKINETICS AND IMMUNOGENICITY OF HD204 TO AVASTIN® IN PATIENTS WITH LUNG CANCER.on-squamous Non-small Cell Lung Cancer (nsNSCLC)MedDRA version: 20.0Level: LLTClassification code 10079440Term: Non-squamous non-small cell lung cancerSystem Organ Class: 100000004864EUCTR2017-005175-78-LVPrestige BioPharma Limited592
进行中（未招募）
1 期
AN EQUIVALENCE TRIAL TO COMPARE THE EFFICACY, SAFETY, PHARMACOKINETICS AND IMMUNOGENICITY OF HD204 TO AVASTIN® IN PATIENTS WITH LUNG CANCER.EUCTR2017-005175-78-HUPrestige BioPharma Pte Ltd592